In addition to the above-mentioned role of the IDO/TDO-Kyn-AhR pathway in cancer development, many studies have demonstrated that kynurenine activation of AhR induces immunosuppressive effects, with the generation of immune-tolerant dendritic cells (DCs) and regulatory T cells. The gene discussed is TDO2; the disease is cancer.